We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,802 hedge funds and large institutions have $249B invested in Johnson & Johnson in 2024 Q2 according to their latest regulatory filings, with 162 funds opening new positions, 1,507 increasing their positions, 1,791 reducing their positions, and 154 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $2.12B | Put options by funds: $1.78B

1.01% more ownership

Funds ownership: 69.87%70.88% (+1%)

5% more first-time investments, than exits

New positions opened: 162 | Existing positions closed: 154

1% less funds holding

Funds holding: 3,8493,802 (-47)

6% less capital invested

Capital invested by funds: $266B → $249B (-$16.5B)

16% less repeat investments, than reductions

Existing positions increased: 1,507 | Existing positions reduced: 1,791

19% less funds holding in top 10

Funds holding in top 10: 204165 (-39)

Holders
3,802
Holders Change
-47
Holders Change %
-1.22%
% of All Funds
54.9%
Holding in Top 10
165
Holding in Top 10 Change
-39
Holding in Top 10 Change %
-19.12%
% of All Funds
2.38%
New
162
Increased
1,507
Reduced
1,791
Closed
154
Calls
$2.12B
Puts
$1.78B
Net Calls
+$333M
Net Calls Change
-$99.1M
Name Holding Trade Value Shares
Change
Change in
Stake
BDWCC
426
B&D White Capital Company
Texas
$31.1M -$9.67M -65,045 -23%
LCS
427
Levin Capital Strategies
New York
$31M -$155K -1,041 -0.5%
HTHT
428
Hemenway Trust Hemenway Trust
New Hampshire
$31M -$26.8K -180 -0.1%
CTA
429
Chesley Taft & Associates
Illinois
$30.8M +$353K +2,373 +1%
RC
430
RBO & Co
California
$30.7M -$37.6K -253 -0.1%
ZIC
431
ZWJ Investment Counsel
Georgia
$30.5M +$1.14M +7,685 +4%
ELI
432
Empire Life Investments
Ontario, Canada
$30.5M -$1.45M -9,769 -4%
WTC
433
WhitTier Trust Company
Nevada
$30.4M -$321K -2,156 -1%
ELC
434
Edgar Lomax Company
Virginia
$30.4M -$392K -2,635 -1%
FP
435
Foundry Partners
Minnesota
$30.3M +$7.82M +52,585 +34%
AWM
436
Absher Wealth Management
North Carolina
$30.2M +$12.5M +83,730 +68%
OPERF
437
Oregon Public Employees Retirement Fund
Oregon
$30.2M +$154K +1,038 +0.5%
WFMPM
438
Woodley Farra Manion Portfolio Management
Indiana
$30.2M +$606K +4,075 +2%
TAM
439
Troy Asset Management
United Kingdom
$29.8M -$4.14M -27,858 -12%
NSLI
440
Nan Shan Life Insurance
Taiwan
$29.4M
CFC
441
Cincinnati Financial Corp
Ohio
$29.4M
BF
442
BOK Financial
Oklahoma
$29.4M -$7.72M -51,899 -21%
EWM
443
Evercore Wealth Management
New York
$29.2M -$786K -5,287 -3%
CIA
444
Choate Investment Advisors
Massachusetts
$29.1M +$1.88M +12,627 +7%
LA
445
LBP AM
France
$29M +$1.34M +9,005 +5%
TC
446
Torno Capital
Massachusetts
$28.9M +$29.5M +198,020 New
AI
447
Atria Investments
North Carolina
$28.9M -$3.38M -22,749 -10%
GIBU
448
Gulf International Bank (UK)
United Kingdom
$28.9M -$2.02M -13,570 -6%
CIM
449
Corda Investment Management
Texas
$28.9M +$727K +4,889 +3%
AAS
450
Avantax Advisory Services
Texas
$28.8M +$9.48M +63,765 +48%

JNJ Hedge Fund Activity: Q2 2024 in Review

3,802 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2024, worth a combined $249B — down 6.2% from $266B a quarter earlier.

Buyers outnumbered sellers: 162 funds opened new JNJ positions and 154 closed out — a net gain of 8 holders — while 1,507 added to existing stakes and 1,791 trimmed.

The largest buyer was BlackRock, adding an estimated $1.26B. The largest seller was Capital International Investors, cutting an estimated $1.8B.

  • 3,802 institutional investors held Johnson & Johnson (JNJ) as of Q2 2024, down from 3,849 in Q1 2024.
  • Funds reported $249B of Johnson & Johnson stock for Q2 2024, down 6.2% quarter-over-quarter.
  • 162 funds opened new Johnson & Johnson positions in Q2 2024 and 154 closed out, a net change of +8 holders.
  • The largest Johnson & Johnson buyer in Q2 2024 was BlackRock, an estimated $1.26B added.
  • The largest Johnson & Johnson seller in Q2 2024 was Capital International Investors, an estimated $1.8B sold.

Based on aggregated 13F filings for Q2 2024.